When Daniel Hwang got out of his second residential rehab in Delray Beach, the discharge counselor handed him a brochure for a sober house ten minutes away. Daniel had bipolar I disorder. He had been stabilized on lithium and quetiapine for almost two years. The medications were the reason he had finally been able to stay clean from cocaine long enough to complete treatment. The house manager met him at the door and explained the rules over a clipboard. No alcohol. No drugs. Random testing. Curfews. And, almost as an afterthought near the bottom of page two, “all residents are required to taper off psychiatric medications within ninety days.” Daniel asked what would happen if he could not. The manager shrugged and said the house was abstinence-based, that medications were a crutch, and that real recovery meant being free of all chemicals. Two weeks later, off lithium, Daniel was manic, then psychotic, then back in a hospital, and within four months had relapsed on cocaine. The sober house was, by its own definition, doing him a favor. By any honest medical definition, it nearly killed him.
The Historical Bias Against Psychiatric Medications
For most of the twentieth century, the American twelve-step tradition treated psychiatric medications with deep suspicion. The original Big Book predated modern psychopharmacology by decades. Sponsors and old-timers, working from a model that defined recovery as freedom from mind-altering chemicals, did not always distinguish between cocaine and a maintenance SSRI. AA itself eventually published a pamphlet titled “The AA Member, Medications and Other Drugs” in 1984, formally clarifying that prescribed medications taken as directed are compatible with the program. The pamphlet did not, however, fully end the bias on the ground.
Sober living homes inherited the bias and often amplified it. House rules written in the 1990s and early 2000s sometimes required residents to taper off antidepressants, mood stabilizers, antipsychotics, and especially anything used for opioid use disorder. The harm caused by those rules has been one of the most under-discussed scandals in American behavioral health. Co-occurring sober living as a distinct category exists because the larger sober living field has, in many corners, refused to keep up with what twenty-first-century psychiatry knows.
What Actually Happens When You Stop Psychiatric Medications
For someone with stable bipolar disorder, abrupt discontinuation of lithium roughly doubles the risk of recurrence within six months. Stopping an SSRI in someone with recurrent major depressive disorder produces relapse rates of forty to sixty percent within a year. Discontinuing an antipsychotic in stable schizophrenia produces relapse rates approaching eighty percent. These are not soft outcomes. They are hospitalizations, suicides, and breakdowns of the work the patient has spent years building.
Layer in active substance use disorder and the picture is worse. Untreated psychiatric illness is the single strongest predictor of relapse to substance use. The bidirectional pull means a person whose mood stabilizer is taken away is highly likely to drink or use to manage the resulting symptoms within months. The clean-from-medications ideology of older sober living homes therefore actively produces relapses while claiming to prevent them. For the clinical case for integrated treatment, see our dual diagnosis treatment guide.
What Co-Occurring Sober Living Actually Means
A legitimate co-occurring sober living home welcomes residents with mental health diagnoses, requires that prescribed medications be taken as directed, and treats psychiatric medication adherence as a recovery behavior, not a violation of recovery. The intake process asks for the resident’s psychiatrist’s contact information. The house manager keeps medications in a locked box and observes morning and evening doses if required. The house rules explicitly list buprenorphine, methadone, antidepressants, antipsychotics, mood stabilizers, ADHD stimulants, and benzodiazepines (when prescribed for documented anxiety disorders) as permitted with prescription.
The cultural shift inside such a home is real. Residents are not made to feel ashamed of taking lithium. House meetings address mental health and substance use as two halves of the same recovery, not as competing concerns. The house manager has training in mental health first aid and knows the warning signs of decompensation. The relationship with each resident’s outpatient psychiatrist is collaborative, not adversarial.
The NARR Standards on Medication
The National Alliance for Recovery Residences, known as NARR, publishes the only national accreditation standard for sober living homes. Standard 4.A.10 specifically addresses medication. NARR-certified residences must accept residents who are taking prescribed medications, including medications for opioid use disorder, and may not require residents to taper off prescribed medications as a condition of residency. Affiliate state organizations, like the Florida Association of Recovery Residences, enforce the standard locally and revoke certification from homes that violate it.
NARR certification is voluntary. A home does not have to be certified to operate, and an enormous share of the sober living industry, particularly in Florida, Arizona, California, and Texas, operates without it. State licensure for recovery residences is patchwork and weak in most states. The practical takeaway is that NARR certification is the strongest single signal that a sober living home will respect psychiatric medication and is therefore the place to start when vetting a potential co-occurring sober living home for yourself or a family member.
How to Vet a Sober Living Home for COD Acceptance
The questions to ask are blunt. “Do you accept residents on lithium, SSRIs, antipsychotics, and mood stabilizers without requiring them to taper?” “Do you accept residents on buprenorphine or methadone for opioid use disorder, with no time-limited expectation of stopping?” “Do you have a relationship with a psychiatrist who treats your residents, or do you require us to use our own?” “What is your protocol if a resident’s mental health symptoms worsen?” “Can I see your house rules in writing before I sign anything?” “Are you NARR-certified, and if so, what is your affiliate?”
An honest house answers these questions in plain language without pivoting to brochure speak. A house that hesitates, says “we’ll work with your situation,” or attaches conditions that shift over time is a house to avoid. The choice between clean sober living models and ones that integrate medication is a recurring theme; for a broader comparison of housing options, see our piece on sober living versus halfway house. For residents on medication for opioid use disorder, our methadone versus suboxone guide explains the medication realities the home should be ready to support.
The Florida Shuffle and What It Reveals
The Florida Shuffle is the term for the cycle in which a patient is admitted to a treatment center, completes thirty days, transitions to an affiliated sober living home, relapses (sometimes after being given access to drugs by predatory operators), gets readmitted to a different treatment center, and so on, often for months or years until the insurance benefits are exhausted. The state of Florida has prosecuted dozens of operators since 2017, and reforms have tightened the rules, but the underlying business model still exists in pockets.
The pattern is most damaging for residents with co-occurring disorders because the cycle of relapses interrupts psychiatric treatment as well as substance use treatment. A patient with bipolar disorder going through three or four sober homes in a year almost never has consistent psychiatric care. The medications get changed, then stopped, then restarted by a new prescriber who does not know the history. By the time the cycle ends, the patient’s underlying psychiatric illness has often deteriorated to the point where stabilization is harder than it was before treatment began. The lesson is that co-occurring sober living needs to be paired with continuity of psychiatric care, not just continuity of recovery housing.
Working With Your State Mental Health Authority
Every state has a single state agency for mental health and a single state agency for substance use, sometimes combined. The state mental health authority typically maintains a list of supportive housing programs designed for people with serious mental illness, some of which also accept co-occurring substance use. These are different from sober homes; they are funded through Medicaid, HUD, and state appropriations, and they are designed from the ground up around psychiatric medication adherence. They tend to be harder to access (waiting lists are real) but the fit is often better for residents whose primary diagnosis is psychiatric and whose substance use is secondary.
The state substance use authority increasingly funds COD-specific recovery housing as well, especially with opioid settlement money. Some states have launched dedicated COD recovery housing programs that combine the peer-staffed culture of traditional sober homes with the medication-friendly, mental-health-aware staffing of supportive housing. Asking your state authority for “recovery housing for people with co-occurring disorders” is the right way to start the conversation, and most states will provide a current list within a few business days.
The Cost Picture
Sober living houses are largely self-pay. Monthly rent runs $500 to $1,500 in most markets, $1,500 to $3,500 in luxury programs in California and Florida. Insurance generally does not cover the room and board, although some plans cover the clinical services delivered while the resident is in the home (IOP, individual therapy, psychiatric visits). Medicaid in some states will cover supportive housing for residents with serious mental illness through 1115 waivers or specific HCBS authorities. State opioid settlement dollars are increasingly subsidizing recovery housing for the population that cannot afford private-pay rent.
Length of stay varies from a few months to two or more years. Outcomes data, while imperfect, consistently shows that residents who stay six months or more have substantially better recovery outcomes than those who leave sooner. The financial reality is that many residents cannot afford that length of stay without family support, and the affordability gap is one of the larger problems in American recovery housing.
Frequently Asked Questions
Will a co-occurring sober house let me stay on Suboxone?
A genuine COD-accepting house, particularly one NARR-certified, will accept buprenorphine residents without time limits. Always confirm in writing before moving in, because some homes claim openness verbally then pressure tapering once you are inside.
Can I keep my own psychiatrist while in a sober home?
Yes. A reasonable house will work with whatever outpatient prescriber you already have. Some homes have an in-house psychiatrist available for residents who need one, but they should not require you to switch.
What happens if I have a mental health crisis in the house?
The house should have a crisis protocol that includes contacting your psychiatrist, taking you to a crisis stabilization unit if needed, and holding your bed during a brief inpatient stay. A house that discharges you for needing psychiatric hospitalization is not a co-occurring house regardless of how it markets itself.
Are co-occurring sober homes more expensive?
Not necessarily. The medication-friendly orientation is a policy difference, not a service-level difference. Costs track local rents and amenities, not COD acceptance.
Can the home tell my family about my diagnosis?
Without your written authorization, no. HIPAA and 42 CFR Part 2 protections apply to any release of psychiatric or substance use information. Sober homes that disclose information without permission are violating federal law.
The Bottom Line
A genuine co-occurring sober living home is the difference between a recovery experience that builds on psychiatric stability and one that strips it away. The questions to ask are simple. The standards to look for, especially NARR certification, are public. The bias against psychiatric medication that haunted older sober living models is, in 2026, an avoidable risk for anyone willing to do the homework. If a house cannot answer the medication questions clearly and in writing, it is not the right house for someone with a co-occurring diagnosis. The right house exists, increasingly often, in every market, and the difference it makes for the resident’s long-term outcome is the difference between recovery that lasts and the cycle that does not.
For the national recovery residence accreditation standards, visit NARR. For SAMHSA‘s Best Practices for Recovery Housing and the federal guidance on medication acceptance in sober living, visit SAMHSA.
Crisis Support
If you or someone you love is in mental health crisis, including thoughts of suicide, call or text 988 to reach the Suicide and Crisis Lifeline. SAMHSA’s National Helpline at 1-800-662-HELP (4357) is free, confidential, and available 24/7 to help you locate co-occurring-friendly recovery housing in your area.
This article is for informational purposes only and does not constitute medical advice. Decisions about psychiatric medication and recovery housing should be made in collaboration with your psychiatrist and treatment team. Never stop or taper psychiatric medication on the advice of a non-clinician or a sober living operator.